Companies: 10,795·Total market cap: $144.5T
Nutriband Inc.

Nutriband Inc.

NTRBNASDAQHealthcare● Active
$3.45
$-0.08(-2.27%)
Market Cap$41938200
P/E Ratio
52W High$11.678
52W Low$3.209

Nutriband Inc. (NTRB) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ntrb · pe ratio · data through Jan 31, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Nutriband Inc. (NTRB) measures how much investors pay for each dollar of the company's trailing earnings. NTRB's current PE ratio of N/A is calculated by dividing its stock price of $3.45 by its TTM earnings per share of -$0.68.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2026-01-31

Forward P/E
2.20x
FY2027 est. EPS $1.57
Based on 1 analyst
EPS (TTM)
-$0.68
TTM · diluted EPS
PEG Ratio
0.02
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nutriband Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2026 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Nutriband Inc.
Nutriband Inc.You
NTRB
$42MN/A-$0.68
Adicet Bio, Inc.
Adicet Bio, Inc.
ACET
$69MN/A-$16.95
Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock
ACRV
$46MN/A-$2.02
Adagene Inc.
Adagene Inc.
ADAG
$123MN/A-$0.47
CervoMed Inc.
CervoMed Inc.
CRVO
$26MN/A-$2.98
Fortress Biotech, Inc.
Fortress Biotech, Inc.
FBIO
$99M14.98x$0.24
Gain Therapeutics, Inc.
Gain Therapeutics, Inc.
GANX
$71MN/A-$0.61

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 11 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2026-01-31Latest
FY2026
$-0.71
2025-01-31
FY2025
$-0.99
2024-01-31
FY2024
$-0.69
2023-01-31
FY2023
$-0.57
2022-01-31
FY2022
$-1.06
2021-01-31
FY2021
$-0.48
2020-01-31
FY2020
$-0.44
2019-01-31
FY2019
$-0.53
2018-01-31
FY2018
$-0.48
2017-01-31
FY2017
$-0.02

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Nutriband Inc. (NTRB) measures how much investors pay for each dollar of the company's trailing earnings. NTRB's current PE ratio of N/A is calculated by dividing its stock price of $3.45 by its TTM earnings per share of -$0.68.

PE Ratio = Stock Price ÷ EPS (TTM)
= $3.45 ÷ -$0.68 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NTRB pe ratio · 6 questions

NTRB's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.45 and TTM EPS of -$0.68. Data sourced from Financial Modeling Prep via NTRB's SEC 10-K and 10-Q filings.

NTRB PE ratioWhat is NTRB PE ratioCurrent PE ratio of NTRBNTRB PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nutriband Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09